本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Anaptysbio Inc

21.19
-0.5100-2.35%
盤後21.190.00000.00%16:05 EDT
成交量:29.44萬
成交額:631.50萬
市值:6.50億
市盈率:-4.14
高:21.90
開:21.88
低:21.15
收:21.70
資料載入中...
2024/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/08/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/06

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report